FBC
LUMO

Fairfield, Bush & Co’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Fairfield, Bush & Co’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-758
Closed -$248K – 140
2015
Q4 		$248K Buy
+758
New +$247K 0.09% 127
2015
Q2 		– Sell
-514
Closed -$253K – 171
2015
Q1 		$253K Buy
+514
New +$199K 0.07% 151

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fairfield, Bush & Co's LUMO Position: Q1 2016 in Review

Fairfield, Bush & Co sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2016, closing a stake of 758 shares — an estimated $248K sold.

Fairfield, Bush & Co first reported a position in LUMO in Q1 2015 and held it in 2 quarters. The position peaked at $253K in Q1 2015. 139 funds tracked by Wall St. Rank hold LUMO as of Q1 2016.

  • Fairfield, Bush & Co reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Fairfield, Bush & Co sold 758 Lumos Pharma, Inc. Common Stock shares in Q1 2016, an estimated $248K.
  • Fairfield, Bush & Co first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • Fairfield, Bush & Co's Lumos Pharma, Inc. Common Stock position peaked at $253K in Q1 2015.
  • 139 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2016.

Based on Fairfield, Bush & Co's 13F filing for Q1 2016, filed 13 May 2016.